M&T Bank
ARIA

M&T Bank’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

M&T Bank’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-19,482
Closed -$161K – 2155
2015
Q2 		$161K Sell
19,482
-280
-1% -$2.48K ﹤0.01% 1821
2015
Q1 		$163K Sell
19,762
-240
-1% -$1.77K ﹤0.01% 1793
2014
Q4 		$138K Sell
20,002
-7,100
-26% -$44.4K ﹤0.01% 1834
2014
Q3 		$147K Buy
+27,102
New +$158K ﹤0.01% 1964

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

M&T Bank's ARIA Position: Q3 2015 in Review

M&T Bank sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2015, closing a stake of 19,482 shares — an estimated $161K sold.

M&T Bank first reported a position in ARIA in Q3 2014 and held it in 4 quarters. The position peaked at $163K in Q1 2015. 175 funds tracked by Wall St. Rank hold ARIA as of Q3 2015.

  • M&T Bank reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
  • M&T Bank sold 19,482 Ariad Pharmaceuticals Inc shares in Q3 2015, an estimated $161K.
  • M&T Bank first reported a position in Ariad Pharmaceuticals Inc in Q3 2014 and held it in 4 quarters.
  • M&T Bank's Ariad Pharmaceuticals Inc position peaked at $163K in Q1 2015.
  • 175 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.